Atlas Trials

Pulse Biosciences, Inc.

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Pulse Biosciences, Inc.

RecordFirmDate
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation (NCT06959121)Pulse Biosciences, Inc.2025-10-23
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System (NCT07287176)Pulse Biosciences, Inc.2025-08-21
CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation (NCT06355063)Pulse Biosciences, Inc.2024-07-31
CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation (NCT06696170)Pulse Biosciences, Inc.2024-07-25
CellFX ® Percutaneous Electrode (PE) Treatment of Symptomatic Benign Thyroid Nodules (NCT06117085)Pulse Biosciences, Inc.2023-04-13
CellFX Treat & Resect Low-Risk BCC Feasibility Study (NCT04918381)Pulse Biosciences, Inc.2021-06-02
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts (NCT04738734)Pulse Biosciences, Inc.2021-02-16
Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions (NCT04539886)Pulse Biosciences, Inc.2020-09-28
CellFX System for the Treatment of Cutaneous Non-Genital Warts (NCT04554394)Pulse Biosciences, Inc.2019-07-17
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study (NCT04249115)Pulse Biosciences, Inc.2019-02-05
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study (NCT04253418)Pulse Biosciences, Inc.2018-12-20
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia (NCT03612570)Pulse Biosciences, Inc.2018-06-28

Track Pulse Biosciences, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.